• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1982-2016 年伊朗东北部霍拉马巴德市多发性硬化症的流行病学研究。

Epidemiology of Multiple Sclerosis in Torbat-e Heydarieh (Northeast of Iran) during 1982-2016.

机构信息

School of Health, Neyshabur University of Medical Sciences, Neyshabur, Iran.

School of Health, Torbat Heydariyeh University of Medical Sciences, Torbat Heydariyeh, Iran.

出版信息

Mult Scler Relat Disord. 2018 Aug;24:184-189. doi: 10.1016/j.msard.2018.07.008. Epub 2018 Jul 7.

DOI:10.1016/j.msard.2018.07.008
PMID:30077941
Abstract

It was believed that the risk of multiple sclerosis (MS) is associated with latitude gradient. Due to the increasing prevalence of MS in some areas around the equator such as Iran, this theory has been criticized in recent years. Since the distribution of MS in Iran is not uniform, this study was designed to describe the prevalence and incidence of MS in the northeastern area of Iran. The patients were registered in the MS center of Torbat-e Heydarieh County and all of them were living in this county during the study period (during 1 January 1982 to 31 December 2016). Data of the patients were extracted from their files in the MS center. Because of the long-term span of this study, we used different diagnosis criteria according to the files of the patients to proven case missing. In addition, population data were obtained from the website of Statistical Centre of Iran. The total number of the MS patients during the study period was 110 cases. The prevalence of the disease at the beginning and end of the research period was 0.33 (95% CI, 0.008-1.85) and 30.48 (95% CI, 25.25-37.03) patients per 100,000 persons, respectively. The incidence of the disease in this 36-year period was 1.41 (95%CI, 1.15-1.69) patients per 100,000 persons. The average age of the patients was 35.01 (95% CI, 33.37-36.65) years and the female to male ratio was 2.8:1. The prevalence of MS has been increased in the 36-year period in Torbat-e Heydarieh, especially for women. More epidemiological studies are needed to determine the factors affecting this increasing trend.

摘要

据信,多发性硬化症(MS)的风险与纬度梯度有关。由于赤道附近的一些地区(如伊朗)MS 的患病率不断增加,近年来这一理论受到了批评。由于伊朗的 MS 分布不均匀,因此本研究旨在描述伊朗东北部地区 MS 的患病率和发病率。患者在 Torbat-e Heydarieh 县的 MS 中心登记,在研究期间(1982 年 1 月 1 日至 2016 年 12 月 31 日)他们都居住在该县。从 MS 中心的患者档案中提取患者的数据。由于本研究时间跨度较长,我们根据患者的档案使用了不同的诊断标准来证明缺失病例。此外,人口数据从伊朗统计中心的网站获得。在研究期间,MS 患者的总数为 110 例。研究开始和结束时,疾病的患病率分别为 0.33(95%CI,0.008-1.85)和 30.48(95%CI,25.25-37.03)每 10 万人中有 100,000 人。在这 36 年期间,该疾病的发病率为 1.41(95%CI,1.15-1.69)每 10 万人中有 100,000 人。患者的平均年龄为 35.01(95%CI,33.37-36.65)岁,男女比例为 2.8:1。在 Torbat-e Heydarieh,MS 的患病率在 36 年期间有所增加,尤其是在女性中。需要进行更多的流行病学研究来确定影响这一增长趋势的因素。

相似文献

1
Epidemiology of Multiple Sclerosis in Torbat-e Heydarieh (Northeast of Iran) during 1982-2016.1982-2016 年伊朗东北部霍拉马巴德市多发性硬化症的流行病学研究。
Mult Scler Relat Disord. 2018 Aug;24:184-189. doi: 10.1016/j.msard.2018.07.008. Epub 2018 Jul 7.
2
Incidence and prevalence of multiple sclerosis in southeastern Iran.伊朗东南部多发性硬化症的发病率和患病率
Clin Neurol Neurosurg. 2013 Mar;115(3):304-8. doi: 10.1016/j.clineuro.2012.05.032. Epub 2012 Jun 18.
3
Prevalence of multiple sclerosis in Isfahan, Iran.伊朗伊斯法罕多发性硬化症的患病率。
Neuroepidemiology. 2006;27(1):39-44. doi: 10.1159/000094235. Epub 2006 Jun 27.
4
Multiple sclerosis in Isfahan, Iran.伊朗伊斯法罕的多发性硬化症
Int Rev Neurobiol. 2007;79:357-75. doi: 10.1016/S0074-7742(07)79016-5.
5
Temporal trends of incidence and prevalence of multiple sclerosis in Razavi Khorasan Province, Northeast Iran.伊朗东北部拉扎维呼罗珊省多发性硬化症的发病率和患病率的时间趋势。
Neurol Sci. 2022 Jan;43(1):583-591. doi: 10.1007/s10072-021-05280-5. Epub 2021 May 3.
6
Multiple sclerosis in the far north--incidence and prevalence in Nordland County, Norway, 1970-2010.挪威最北部的多发性硬化症——1970 - 2010年挪威诺尔兰郡的发病率和患病率
BMC Neurol. 2014 Dec 4;14:226. doi: 10.1186/s12883-014-0226-8.
7
Sharp increase in the incidence and prevalence of multiple sclerosis in Isfahan, Iran.伊朗伊斯法罕多发性硬化症发病率和患病率急剧上升。
Mult Scler. 2011 Aug;17(8):1022-7. doi: 10.1177/1352458511401460. Epub 2011 Apr 1.
8
Estimated prevalence and incidence of multiple sclerosis in Iran.伊朗多发性硬化症的估计患病率和发病率。
Eur Neurol. 2014;72(5-6):370-4. doi: 10.1159/000365846. Epub 2014 Oct 18.
9
A 20-year incidence trend (1989-2008) and point prevalence (March 20, 2009) of multiple sclerosis in Tehran, Iran: a population-based study.伊朗德黑兰多发性硬化症的 20 年发病趋势(1989-2008 年)和时点患病率(2009 年 3 月 20 日):一项基于人群的研究。
Neuroepidemiology. 2011;36(3):141-7. doi: 10.1159/000324708. Epub 2011 Apr 20.
10
Evidence of an increased prevalence of multiple sclerosis: a population-based study of Tehran registry during 1999-2018.多发性硬化症患病率增加的证据:1999-2018 年德黑兰注册中心的一项基于人群的研究。
BMC Neurol. 2020 May 2;20(1):169. doi: 10.1186/s12883-020-01747-8.

引用本文的文献

1
Frequency of Registered Cases of Multiple Sclerosis.多发性硬化症登记病例的频率。
Maedica (Bucur). 2023 Jun;18(2):216-221. doi: 10.26574/maedica.2023.18.2.216.
2
Multiple sclerosis incidence rate in southern Iran: a Bayesian epidemiological study.伊朗南部多发性硬化症发病率:一项贝叶斯流行病学研究。
BMC Neurol. 2021 Aug 10;21(1):309. doi: 10.1186/s12883-021-02342-1.
3
Heat Exposure and Multiple Sclerosis-A Regional and Temporal Analysis.热暴露与多发性硬化症的区域性和时间性分析。
Int J Environ Res Public Health. 2021 Jun 2;18(11):5962. doi: 10.3390/ijerph18115962.
4
Multiple sclerosis in Iran: An epidemiological update with focus on air pollution debate.伊朗的多发性硬化症:聚焦空气污染争议的流行病学最新情况
J Clin Transl Res. 2021 Feb 17;7(1):49-60. eCollection 2021 Feb 25.
5
Prevalence of Multiple Sclerosis (MS) in Zanjan Province of Iran.伊朗赞詹省多发性硬化症(MS)的患病率。
Int J Prev Med. 2020 Aug 6;11:116. doi: 10.4103/ijpvm.IJPVM_419_19. eCollection 2020.
6
A cross-sectional study of alexithymia in patients with relapse remitting form of multiple sclerosis.复发缓解型多发性硬化症患者述情障碍的横断面研究。
J Postgrad Med. 2020 Jan-Mar;66(1):23-27. doi: 10.4103/jpgm.JPGM_499_19.